Skip to main content
Tadiran Group Ltd. logo

Tadiran Group Ltd. — Investor Relations & Filings

Ticker · TDRN ISIN · IL0002580129 TA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 169 across all filing types
Latest filing 2023-03-16 Major Shareholding Noti…
Country IL Israel
Listing TA TDRN

About Tadiran Group Ltd.

https://www.tadiran-group.co.il

Tadiran Group Ltd. is a company specializing in advanced climate control and renewable energy solutions. The company develops, imports, and distributes a wide range of air conditioning systems for residential and light commercial applications, with a significant focus on indoor air quality through integrated air purification and disinfection technologies. In the energy sector, Tadiran provides a comprehensive portfolio of solutions including solar energy systems, energy storage, heat pumps for water and space heating, and electric vehicle charging stations. The company's offerings aim to create an ecosystem for energy efficiency and sustainability.

Recent filings

Filing Released Lang Actions
Form 8.5 (EPT/NON-RI)
Major Shareholding Notification Classification · 97% confidence The document is explicitly titled 'FORM 8.5 (EPT/NON-RI)' and references 'Rule 8.5 of the Takeover Code'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER'. This type of filing relates to insider trading disclosures during a takeover or merger situation, specifically detailing positions and dealings of an exempt principal trader connected to an offeror or offeree (Mediclinic International Plc). This specific disclosure requirement falls under regulatory reporting related to takeovers, which is best categorized as a general Regulatory Filing (RNS) or potentially Director's Dealing (DIRS) if it were a director, but since it's a specific Takeover Code disclosure by a principal trader, RNS is the most appropriate general regulatory category, as DIRS is usually reserved for directors/executives. Given the options, RNS serves as the best fit for specific, non-standard regulatory disclosures like this one concerning takeover rules.
2023-03-16 English
Form 8.5 (EPT/NON-RI)
Regulatory Filings Classification · 98% confidence The document is explicitly titled 'FORM 8.5 (EPT/NON-RI)' and references 'Rule 8.5 of the Takeover Code'. This form is a specific regulatory disclosure related to dealings by an Exempt Principal Trader concerning an offer (takeover/merger) involving Mediclinic International Plc. This type of filing, which reports insider/principal trader transactions related to a specific corporate action (like a takeover bid), is a form of regulatory disclosure. Since there is no specific category for 'Takeover Code Disclosure' or 'Insider Dealing related to a Bid', and it is a mandatory regulatory filing distributed via RNS, the most appropriate classification is 'Regulatory Filings' (RNS), as it is a general regulatory announcement that doesn't fit the other specific categories like DIRS (which is usually for routine director dealings, not bid-related principal trader disclosures) or TAR (which is for the M&A announcement itself, not the subsequent trading disclosures). The presence of RNS headers and the distribution method strongly support RNS.
2023-03-15 English
Company presentation-March 2023
Investor Presentation Classification · 98% confidence The document is titled "Company Presentation 2023 March" and contains extensive slides detailing the company's vision, structure, business segments (Air Conditioning, Solar Energy, Energy Solutions), technological advancements (like the TM3 Airow purification technology), and a detailed section on "2022 - Financial results" including quarterly and full-year figures, followed by a "2026 Tadiran Summary strategic plan". This structure—a comprehensive overview of the past year's performance combined with future strategic goals and market positioning—is characteristic of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K or IR, nor is it a brief announcement (RPA/RNS).
2023-03-15 English
Company presentation-March 2023
Report Publication Announcement Classification · 99% confidence The document text is very short (2771 characters) and contains a clear reference to a file attachment: "����� ���� *Tadiran_Group_Ltd_Company_presentation_FY2022_isa.pdf*". It also includes a publication date and time ("����� �� ���� ������ ������� �� �����: *15/03/2023* ����: *08:00*"). This structure strongly suggests an announcement about the release of a report rather than the full report itself. The title mentions "Company presentation FY2022". A company presentation aligns best with the Investor Presentation (IP) category, but because this document is merely announcing the publication of that presentation, it fits the Report Publication Announcement (RPA) definition best, following Rule 2 ("MENU VS MEAL").
2023-03-15 Russian
Form 8.5 (EPT/NON-RI)
M&A Activity Classification · 100% confidence The document is explicitly titled 'FORM 8.5 (EPT/NON-RI)' and references 'Rule 8.5 of the Takeover Code'. This form is used for 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER' in relation to an offer (specifically mentioning Mediclinic International Plc). This type of disclosure, mandated by takeover regulations, concerns insider dealings or position changes during a takeover scenario. While it involves director/insider activity (similar to DIRS), the specific context of a Takeover Code disclosure (Form 8.5) dealing with an offer makes it a specialized regulatory filing related to market activity during a corporate action. Since there is no specific code for 'Takeover Disclosure', and it is a mandatory regulatory filing disseminated via RNS, it falls best under the general 'Regulatory Filings' (RNS) category, as it is not a standard Director's Dealing (DIRS) form (which typically refers to Form 3, 4, or 5 in the US context, or similar national forms not tied to a specific takeover code rule). Given the structure and mandatory nature of the filing under the Takeover Code, RNS is the most appropriate general regulatory classification.
2023-03-14 English
Form 8.5 (EPT/NON-RI)
Regulatory Filings Classification · 98% confidence The document is explicitly titled 'FORM 8.5 (EPT/NON-RI)' and references 'Rule 8.5 of the Takeover Code'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER'. Such disclosures regarding dealings or positions related to a takeover offer are mandatory regulatory filings, often disseminated via an RNS (Regulatory Information Service) feed, as indicated by the 'RNS Number' and the concluding boilerplate text mentioning RNS and the London Stock Exchange. While it contains specific dealing information, the primary nature of the document is a mandatory regulatory disclosure related to a takeover situation, which fits best under the general 'Regulatory Filings' category (RNS) as it is not one of the more specific financial report types (like 10-K, ER, or IR). It is not a Director's Dealing (DIRS) as it concerns an exempt principal trader's position related to an offer, not routine insider trading disclosure under standard insider trading rules, although it shares similarities. Given the context of a takeover code disclosure disseminated via RNS, RNS is the most appropriate classification.
2023-03-13 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.